{"transactions":[{"id":3990404,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":168211,"kind":"person","name":"RAYNOR DANIEL","position":1,"cik":"0001068854","reported_name":"RAYNOR DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-19T20:54:29.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":5313,"price":60.62,"value":322074.06,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $60.50 to $60.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Argentum Capital Partners II. L.P., which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1)."}],"balance_after":289003,"source":{"system":"sec-edgar","filing":"0001144204-18-015633","document":"tv488937_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418015633/tv488937_form4.xml","form_type":"4"}},{"id":3990403,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":168211,"kind":"person","name":"RAYNOR DANIEL","position":1,"cik":"0001068854","reported_name":"RAYNOR DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-19T20:54:29.000Z","date":"2018-03-15","kind":"sale","acquired":false,"shares":1902,"price":61.5,"value":116973.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $61.00 to $62.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Argentum Capital Partners II. L.P., which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1)."}],"balance_after":294316,"source":{"system":"sec-edgar","filing":"0001144204-18-015633","document":"tv488937_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418015633/tv488937_form4.xml","form_type":"4"}},{"id":3996816,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":168211,"kind":"person","name":"RAYNOR DANIEL","position":1,"cik":"0001068854","reported_name":"RAYNOR DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-14T21:33:43.000Z","date":"2018-03-14","kind":"sale","acquired":false,"shares":1919,"price":62.02,"value":119016.38,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $62.00 to $62.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Argentum Capital Partners II. L.P., which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1)"}],"balance_after":296218,"source":{"system":"sec-edgar","filing":"0001144204-18-014708","document":"tv488553_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418014708/tv488553_form4.xml","form_type":"4"}},{"id":3996815,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":168211,"kind":"person","name":"RAYNOR DANIEL","position":1,"cik":"0001068854","reported_name":"RAYNOR DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-14T21:33:43.000Z","date":"2018-03-13","kind":"sale","acquired":false,"shares":4117,"price":62.59,"value":257683.03,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $62.50 to $63.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Argentum Capital Partners II. L.P., which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1)"}],"balance_after":298137,"source":{"system":"sec-edgar","filing":"0001144204-18-014708","document":"tv488553_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418014708/tv488553_form4.xml","form_type":"4"}},{"id":3996814,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":168211,"kind":"person","name":"RAYNOR DANIEL","position":1,"cik":"0001068854","reported_name":"RAYNOR DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-14T21:33:43.000Z","date":"2018-03-13","kind":"sale","acquired":false,"shares":14000,"price":61.81,"value":865340.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $61.51 to $62.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Argentum Capital Partners II. L.P., which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1)"}],"balance_after":302254,"source":{"system":"sec-edgar","filing":"0001144204-18-014708","document":"tv488553_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418014708/tv488553_form4.xml","form_type":"4"}},{"id":3996813,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":168211,"kind":"person","name":"RAYNOR DANIEL","position":1,"cik":"0001068854","reported_name":"RAYNOR DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-14T21:33:43.000Z","date":"2018-03-12","kind":"sale","acquired":false,"shares":7928,"price":62.88,"value":498512.64,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $62.8223 to $63.037. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Argentum Capital Partners II. L.P., which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1)"}],"balance_after":316254,"source":{"system":"sec-edgar","filing":"0001144204-18-014708","document":"tv488553_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418014708/tv488553_form4.xml","form_type":"4"}},{"id":4362437,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":168211,"kind":"person","name":"RAYNOR DANIEL","position":1,"cik":"0001068854","reported_name":"RAYNOR DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-04-04T22:11:27.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and stock options vest on the first anniversary of the grant date."}],"balance_after":2000,"derivative":{"exercise_price":49.51,"exercise_date":"2017-03-31","expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001144204-17-018967","document":"v463554_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420417018967/v463554_form4.xml","form_type":"4"}},{"id":4362436,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":168211,"kind":"person","name":"RAYNOR DANIEL","position":1,"cik":"0001068854","reported_name":"RAYNOR DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-04T22:11:27.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and stock options vest on the first anniversary of the grant date."}],"balance_after":11110,"source":{"system":"sec-edgar","filing":"0001144204-17-018967","document":"v463554_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420417018967/v463554_form4.xml","form_type":"4"}}]}